Mayer, K <br/><br/>
A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry.  [electronic resource] 

 -  Thrombosis and haemostasis  Aug 2014 
 - 342-51 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH13-10-0874  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Blood Platelets--drug effects<br/>Case-Control Studies<br/>Clopidogrel<br/>Coronary Thrombosis--etiology<br/>Drug Resistance<br/>Drug Substitution<br/>Female<br/>Germany<br/>Hemorrhage--chemically induced<br/>Humans<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Percutaneous Coronary Intervention--adverse effects<br/>Piperazines--adverse effects<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Platelet Function Tests<br/>Prasugrel Hydrochloride<br/>Precision Medicine<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Purinergic P2Y Receptor Antagonists--adverse effects<br/>Receptors, Purinergic P2Y12--blood<br/>Registries<br/>Risk Factors<br/>Thiophenes--adverse effects<br/>Ticlopidine--adverse effects<br/>Time Factors<br/>Treatment Outcome